| bibliographicCitation |
Denholm JT, Davis J, Paterson D, Roberts J, Morpeth S, Snelling T, Zentner D, Rees M, O’Sullivan M, Price D, Bowen A, Tong SYC, Davis J, Denholm J, Tong S, Rees M, Paterson D, Price D, Morpeth S, O’Sullivan M, Roberts J, Snelling T, Anderson S, McQuilton Z, Venkatesh B, Hammond N, Jha V, Burston VJ, McMahon J, Charles P, Commons R, O’Brien D, Mahoney A, Sheffield D, Lim L, Gardiner B, Schulz T, Torresi J, Chean R, Sasadeusz J, Rogers B, Aboltins C, Singh K, Yong M, Lister D, Visvanathan K, Molton J, Tai A, Chalmers R, Martinello M, Wilson P, Gray T, Coghill S, Foo H, Sud A, Williams J, Lwin N, Post J, van Haal S, Sullivan R, Matthews G, Kwan BCH, Slack A, Shum O, Cochrane B, Dotel R, Gray T, Gilbey T, Mina M, Su Y, Trethewy C, Hudson B, Chatterji A, Mostert C, New D, Raby E, Hui S, Robinson O, Hart J, Tan SJ, Arellano A, Chambers J, Davis J, Rafiei N, Smith S, Sehu M, da Silva J, Griffin P, Henderson A, Chaw K, Choong K, Burke A, Heather C, Senanayake S, Boyd M, Rowe E, Anagnostou M, Trad A, Ratcliff A, Morpeth S, Dummer J, Bhally H, Giola M, Grimwade K, Chang CL, Verrall A, Hogg S, Restropo D, Maze M, Ritchie S, Gedye C, Chang J, Maze M, Pillai P, Flanagan K, Mora J, Post J, Lam E, Littleford R, Knoblauch N, Slow S, . The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 14;21(1). doi: 10.1186/s13063-020-04576-9. |